Featured Research

from universities, journals, and other organizations

Glycemic Stability May Be Important Key To Recovery From Critical Illness

Date:
May 20, 2008
Source:
American Thoracic Society
Summary:
Widely varying blood glucose levels may pose as great a threat, or possibly a greater threat, to critically ill patients as high, but steady, glycemic levels.

Widely varying blood glucose levels may pose as great a threat, or possibly a greater threat, to critically ill patients as high, but steady, glycemic levels, according to researchers in Saudi Arabia, who will present their findings at the American Thoracic Society's 2008 International Conference in Toronto on May 20.

"We found that patients with wide fluctuation were significantly more likely to die in the intensive care unit and the hospital than those who experience low glycemic variability," said Hasan M. Al-Dorzi, M.D., who led the research at King AdbulAziz Medical City, in Riyadh. "This finding may lead to further research that changes our focus from only treating high blood glucose to also minimizing changes in glycemic levels."

Other studies have shown that glycemic variability increases diabetic complications. This study is one of the first to evaluate glycemic variability and the outcomes of critically ill patients.

To conduct the study, the researchers evaluated a nested cohort of 523 patients who were prospectively randomized to either intensive or conventional insulin therapy. After evaluating the daily blood glucose range of all the patients and determining a median, the patients were divided into two groups: those with high variability of blood glucose levels and those with low variability.

Patients in the high variability group were 12 percent more likely to die. They were also more likely to develop a nosocomial infection while in the hospital.

The study identified three predictors of glycemic variability: age, previous diabetes history and whether the patient's diabetes was controlled with insulin.

Dr. Al-Dorzi suggested that future research could result in improved care for these patients by establishing a standard definition of high variability and developing ways for minimizing blood glucose changes. The latter, he explained, might require an "automated, continuous blood glucose measurement system with computerized insulin protocols."


Story Source:

The above story is based on materials provided by American Thoracic Society. Note: Materials may be edited for content and length.


Cite This Page:

American Thoracic Society. "Glycemic Stability May Be Important Key To Recovery From Critical Illness." ScienceDaily. ScienceDaily, 20 May 2008. <www.sciencedaily.com/releases/2008/05/080520122835.htm>.
American Thoracic Society. (2008, May 20). Glycemic Stability May Be Important Key To Recovery From Critical Illness. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/05/080520122835.htm
American Thoracic Society. "Glycemic Stability May Be Important Key To Recovery From Critical Illness." ScienceDaily. www.sciencedaily.com/releases/2008/05/080520122835.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins